SEHK:1177Pharmaceuticals
Sino Biopharmaceutical (SEHK:1177) Stock Faces Margin Strain Despite Profit Recovery
Sino Biopharmaceutical stock has been grinding higher in recent weeks, yet today’s reaction hangs almost entirely on one thing. The market is trying to make sense of a solid swing back to profit in H1 2026 while margin pressure refuses to ease.
Basic earnings per share of C¥0.19 and net income of C¥3,434.60m mark a sharp contrast to the loss reported in H2 2025. At the same time, the latest net profit margin of 7.1% sits well below last year’s 12.8%. The question for you is whether today’s...